next ann:initiation of phase iia trial atl1103, page-19

Its amazing how some forget what ANP is currently valued at - look at Biotechs with solid runs on the board and you will see that many are priced at more than 100x the value of ANP and rightly so. Compare also, small miners where there are possibilities of a strike, but where costs to mine might become prohibitive or where world demand can go up and down and have a major impact on a small player - many of these small miners are many multiples of the ANP price and are still a toss-up.

Whether 3 cents or 5 cents or 10 cents, ANP is well within fair value of what it is worth at the early stage where its pipeline is at...and with genuine discussions of licensing etc on more than one of its pipeline, most holders are well within their rights to expect that the price can easily jump to multiples of where it is now.

Thinking longer term, its a juggle about whether a CR may be the better way to go (and delay licensing until the pipeline matures further) versus taking the money on offer earlier. The latter option will see the price rise faster, whereas the earlier option is more about LT benefits.

Hopefully management have good business brains and will do some deals that will be of benefit to both ST and LT holders.